# EnBiotix, Inc. — Form D

EnBiotix, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-05. The offering totals $5.0M, of which $3.5M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2022-04-05
- Form: D
- Accession: 0001789774-22-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $3.5M
- Remaining: $1.5M
- Investors: 11
- Date of first sale: 2019-08-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-440344

## Issuer

- Name: EnBiotix, Inc.
- CIK: 0001789774
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 197 W SPRINGFIELD STREET, BOSTON, MA, 02118
- Phone: 508-400-1856

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Dennis D Auisello | Director | Boston, MA |
| Roberto D Guttmann | Director | Boston, MA |
| Daniel D Hartman | Director | Boston, MA |
| Jeffrey D Wager | Director | Boston, MA |
| Jeffrey D Wager | Executive Officer | Boston, MA |
| Dennis D Ausiello | Director | Boston, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2019-09-30](https://search.stillhousedata.com/formd/0001789774-19-000001) | D | $26.0M | $3.1M |

## More

- [CIK 1789774 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1789774&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001789774-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.